Lymphopenia News and Research

RSS
Lymphopenia is a condition in which there is a lower-than-normal number of lymphocytes (a type of white blood cell) in the blood. Also called lymphocytic leukopenia and lymphocytopenia.
Study identifies immune profile of people with severe COVID-19

Study identifies immune profile of people with severe COVID-19

What are the changes in the physical phenotype of blood cells in COVID-19?

What are the changes in the physical phenotype of blood cells in COVID-19?

Hematological findings in Amazonian patients with COVID-19

Hematological findings in Amazonian patients with COVID-19

Insight into role of aging in response to SARS-CoV-2 infection

Insight into role of aging in response to SARS-CoV-2 infection

SARS-CoV-2-specific T cells are key players in decreasing COVID-19 mortality

SARS-CoV-2-specific T cells are key players in decreasing COVID-19 mortality

High factor V levels linked to lymphopenia and weakened immunity in severe COVID-19

High factor V levels linked to lymphopenia and weakened immunity in severe COVID-19

SARS-CoV-2 RNA in blood serum could predict COVID-19 mortality

SARS-CoV-2 RNA in blood serum could predict COVID-19 mortality

HIV alters SARS-CoV-2 immune response without affecting COVID-19 symptoms or outcomes

HIV alters SARS-CoV-2 immune response without affecting COVID-19 symptoms or outcomes

SARS-CoV-2-specific IgM / IgG responses accurately predict COVID-19 outcome

SARS-CoV-2-specific IgM / IgG responses accurately predict COVID-19 outcome

Preliminary analysis of photon therapy treatment group 1 shows no significant differences between arms

Preliminary analysis of photon therapy treatment group 1 shows no significant differences between arms

Characterization of prognostic markers to predict COVID-19 severity

Characterization of prognostic markers to predict COVID-19 severity

Pathways contributing to hypercoagulability in severe SARS‐CoV‐2 patients

Pathways contributing to hypercoagulability in severe SARS‐CoV‐2 patients

SARS-CoV-2 infects monocytes and macrophages, without cytopathic effect

SARS-CoV-2 infects monocytes and macrophages, without cytopathic effect

LOX-1-immature neutrophils may help identify COVID-19 patients at risk of thrombosis complication

LOX-1-immature neutrophils may help identify COVID-19 patients at risk of thrombosis complication

D-dimer - A sensitive novel biomarker of COVID-19 mortality

D-dimer - A sensitive novel biomarker of COVID-19 mortality

Exponential rise in COVID-19 hospitalization risk with age due to waning T cell immunity

Exponential rise in COVID-19 hospitalization risk with age due to waning T cell immunity

SARS-CoV-2-RNA viremia is a robust marker of critical illness in COVID-19

SARS-CoV-2-RNA viremia is a robust marker of critical illness in COVID-19

Targeted therapy achieves durable objective responses Phase I/II LIBRETTO-001 trial

Targeted therapy achieves durable objective responses Phase I/II LIBRETTO-001 trial

Targeting SARS-CoV-2 with off-the-shelf CAR-NK cells

Targeting SARS-CoV-2 with off-the-shelf CAR-NK cells

COVID-19 patient with repeatedly undetectable SARS-CoV-2 antibodies

COVID-19 patient with repeatedly undetectable SARS-CoV-2 antibodies